[(111)In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial
[(111)In]In-CP04 作为一种新型胆囊收缩素-2 受体配体，具有治疗诊断潜力，可用于治疗进展性或转移性甲状腺髓样癌患者：GRAN-T-MTC I 期临床试验的最终结果
期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-022-05992-6
Lezaic, Luka; Erba, Paola Anna; Decristoforo, Clemens; Zaletel, Katja; Mikolajczak, Renata; Maecke, Helmut; Maina, Theodosia; Konijnenberg, Mark; Kolenc, Petra; Trofimiuk-Müldner, Malgorzata; Przybylik-Mazurek, Elwira; Virgolini, Irene; de Jong, Marion; Fröberg, Alide C; Rangger, Christine; Di Santo, Gianpaolo; Skorkiewicz, Konrad; Garnuszek, Piotr; Solnica, Bogdan; Nock, Berthold A; Fedak, Danuta; Gaweda, Paulina; Hubalewska-Dydejczyk, Alicja
